Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Evidence suggests a greater prevalence of fibromyalgia among people with Behçet's disease than in the general population. Just as fibromyalgia appears to be more prevalent among women than men in the ...

The monoclonal antibody ustekinumab (Stelara), which targets interleukin (IL)-12 and IL-23, appeared to be effective for clearing oral ulcers in Behcet's disease in a multicenter open-label study ...

Please provide your email address to receive an email when new articles are posted on . Patients with vascular manifestations of Behçet’s disease who received treatment with anticoagulants did not ...

The MarketWatch News Department was not involved in the creation of this content. -- Study results support advancing SGX945 in this difficult-to-treat orphan disease -- Results suggest potential ...

Please provide your email address to receive an email when new articles are posted on . The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but ...

LONDON--(BUSINESS WIRE)--According to a recent Technavio report, the Behcet's disease therapeutics market is expected to grow by USD 224.55 million during 2019-2023. Growth in the Behcet's disease ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Behcet's syndrome market. The report includes a detailed analysis of the pipeline molecules under ...

Researchers don't know the exact cause of Behçet's disease, a condition that leads to serious complications such as blindness, but new research brings better understanding to what makes some people ...

Desbois and colleagues evaluated factors associated with relapse of thrombosis and mortality in patients with Behçet disease by performing chart reviews of 807 patients, 296 (37%) of whom had a total ...

SAN DIEGO — Apremilast quickly relieves painful oral and genital ulcers in patients with Behçet's disease and improves quality of life, compared with placebo, results of a phase 2 study suggest. "The ...